← Eichor
Study identifier: NCT05601037 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

LymphoVenous Anastomosis to Prevent Breast Cancer Related Lymphedema

Condition: Lymphedema, Breast Cancer  ·  Sponsor: University Hospital, Ghent

PhaseNA
Planned participants80
Who can joinFemale, 18 Years to 99 Years
Healthy volunteersNo

About this study

Lymphedema is defined as a chronic condition, caused by lymphostasis. A major part in the Western world consists of iatrogenic lymphedema caused by surgery to the lymph nodes of the axilla or groin. Prophylactic lymphovenous anastomosis (LVA) could be beneficial in the prevention of lymphedema of the extremities.

This description comes directly from the study's public registry record.

Talk to the study team

Bernard Depypere, MD  ·  093325730  ·  bernard.depypere@ugent.be

Jessie De Kinder  ·  093321373  ·  jessie.dekinder@uzgent.be

Always discuss trial participation with your own doctor first.

Locations (1)

UZ GENTGhent, Oost-Vlaanderen, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05601037